4//SEC Filing
Musunuri Shankar 4
Accession 0001062993-22-024210
CIK 0001372299other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:07 PM ET
Size
9.8 KB
Accession
0001062993-22-024210
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Musunuri Shankar
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-16$0.51/sh+95,809$48,863→ 848,349 total - Sale
Common Stock
2022-12-16$1.43/sh−95,809$137,007→ 752,540 total - Exercise/Conversion
Option (Right to Buy)
2022-12-16−95,809→ 426,543 totalExercise: $0.51Exp: 2030-01-02→ Common Stock (95,809 underlying)
Holdings
- 1,145,299(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.39 to $1.54. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC.
- [F4]The options, initially representing a right to purchase 933,528 shares, vest and become exercisable in equal annual installments over three years commencing on January 2, 2021, subject to continued service with the Company on the applicable vesting dates.
Issuer
Ocugen, Inc.
CIK 0001372299
Entity typeother
Related Parties
1- filerCIK 0001791820
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:07 PM ET
- Size
- 9.8 KB